| | | | | |
CHRS Coherus Oncology, Inc. Common Stock | €1.1347 | -3.65% | €188.58M | €722.59K | |
| €2.3811 | -0.72% | €186.93M | €2.08K | |
MFM Aberdeen Municipal Income Fund | €4.4699 | -1.33% | €186.93M | €228.22K | |
CHCI Comstock Holding Companies, Inc. Class A | €17.8625 | -0.91% | €186.93M | €108.79K | |
PTAC Patriot Acquisition Corp. Class A Ordinary Shares | €8.5788 | +0.40% | €186.90M | €5.24K | |
ARMP Armata Pharmaceuticals, Inc. Common Stock | €4.6504 | -7.04% | €186.65M | €15.37K | |
EXFY Expensify, Inc. Class A Common Stock | €1.9685 | -3.38% | €186.55M | €360.54K | |
| €54.4857 | +0.63% | €186.36M | €14.60K | |
IIF Morgan Stanley India Investment Fund, Inc. | €19.4442 | -0.83% | €186.22M | €11.95K | |
VYGR Voyager Therapeutics, Inc. Common Stock | €2.7937 | -4.41% | €185.91M | €430.29K | |
MITT TPG Mortgage Investment Trust, Inc. | €5.8453 | +0.30% | €185.90M | €243.65K | |
| €1.4621 | +9.04% | €185.44M | €2.50M | |
PEPG PepGen Inc. Common Stock | €2.7249 | -1.25% | €185.15M | €992.60K | |
PLX Protalix BioTherapeutics, Inc. Common Stock | €2.2951 | +0.76% | €184.92M | €499.07K | |
GSHR Gesher Acquisition Corp. II Class A Ordinary Shares | €9.0344 | -0.38% | €184.79M | €43.12K | |
